Gallagher et al., paper summarizing the 2 landmark Trials PONTIAC 1 and STOP-HF stating the use of NT-pro BNP is an effective tool in refining risk prediction for heart failure and cardiovascular disease and adding predictive power to conventional risk factors (104). The gene discussed is NPPB; the disease is heart failure.